Home   Package List   Routine Alphabetical List   Global Alphabetical List   FileMan Files List   FileMan Sub-Files List   Package Component Lists   Package-Namespace Mapping  
Routine: DVBCWPM1

DVBCWPM1.m

Go to the documentation of this file.
  1. DVBCWPM1 ;ALB/ESW PULMONARY TB AND MYCO. DIS. WKS TEXT - 1 ; 10 Oct 2000
  1. ;;2.7;AMIE;**34**;Apr 10, 1995
  1. ;
  1. TXT ;
  1. ;;A. Review of Medical Records:
  1. ;;
  1. ;;B. Medical History (Subjective Complaints):
  1. ;; Comment on:
  1. ;;
  1. ;; 1. Activity of pulmonary tuberculosis or other mycobacterial disease.
  1. ;; 2. Date of inactivity if it is not active.
  1. ;; 3. Identity of organism (if possible).
  1. ;;
  1. ;;C. Physical examination (Objective Findings):
  1. ;; Address each of the following and fully describe current findings:
  1. ;;
  1. ;; 1. Extent of structural damage to lungs.
  1. ;; 2. If patient was hospitalized for 6 months or more, what is the
  1. ;; condition at the end of hospitalization?
  1. ;; 3. If patient was hospitalized for 12 months or more, what is the
  1. ;; condition at the end of hospitalization?
  1. ;;
  1. ;;D. Diagnostic and Clinical Tests:
  1. ;;Provide:
  1. ;;
  1. ;;1. Pulmonary Function Tests, if indicated. If performed, include the results
  1. ;; in the examination report, The FEV-1,FVC, and FEV-1/FVC should be included.
  1. ;; Both pre- and post-bronchodilatation pulmonary function test results should
  1. ;; be reported. If post-bronchodilatation test is not conducted in a particular
  1. ;; case, please provide an explanation of why not. A DLCO may or may not be
  1. ;; done routinely as part of pulmonary function testing at a particular
  1. ;; facility. If there is a disparity between the results of different tests,
  1. ;; please indicate which tests are more likely to accurately reflect
  1. ;; the severity of the condition.
  1. ;;
  1. ;; DLCO note: If DLCO was not done as a routine part of pulmonary function
  1. ;; testing, the examiner should use his or her judgment, based on
  1. ;; the specific condition (.e.g., whether it is obstructive,
  1. ;; interstitial, etc.) and other available information about the condition,
  1. ;; as to whether a DLCO test is needed, since it is not useful in all
  1. ;; situations. If it may provide useful information about the severity
  1. ;; of the condition, it should be requested and reviewed before
  1. ;; the examination report is submitted. If the examiner determines that
  1. ;; the DLCO test is not needed, a statement as to why not (e.g., there are
  1. ;; decreased lung volumes that would not yield valid test results) should be
  1. ;; included in the report. Such a statement could avoid a remand from BVA
  1. ;; when the test is not done. However in the case of a BVA remand in which
  1. ;; the DLCO is requested, the DLCO MUST be done unless there is a medical
  1. ;; contraindication.
  1. ;;
  1. ;;E. Diagnosis:
  1. ;;
  1. ;; 1. In reactivated cases, is this reactivation of the old disease
  1. ;; or a separate and distinct new infection?
  1. ;;
  1. ;;ADDITIONAL NOTE TO THE EXAMINER:
  1. ;;
  1. ;;In all claims, if the disease is inactive and if the inactivity was confirmed
  1. ;;at a non-VA facility, obtain the name and mailing address of the facility
  1. ;;from the veteran so that the Regional Office may request the report.
  1. ;;
  1. ;;
  1. ;;Signature: Date:
  1. ;;END